跳至主要内容
临床试验/NCT02255123
NCT02255123
已完成
不适用

A Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study (CTOT-18)

National Institute of Allergy and Infectious Diseases (NIAID)12 个研究点 分布在 1 个国家目标入组 178 人2014年10月

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Cardiac Transplantation
发起方
National Institute of Allergy and Infectious Diseases (NIAID)
入组人数
178
试验地点
12
主要终点
Composite incidence of Death, Re-transplantation or re-listed for transplantation, Coronary stent, Myocardial Infarction and Clinical evidence of CAV per ISHLT grading
状态
已完成
最后更新
10年前

概览

简要总结

This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.

注册库
clinicaltrials.gov
开始日期
2014年10月
结束日期
2015年6月
最后更新
10年前
研究类型
Observational
性别
All

研究者

入排标准

入选标准

  • Subjects previously enrolled in the CTOT-05 study
  • Subjects 4 years post-transplant (+/- 6 months).

排除标准

  • Withdrawal of consent from the CTOT-05 study.

结局指标

主要结局

Composite incidence of Death, Re-transplantation or re-listed for transplantation, Coronary stent, Myocardial Infarction and Clinical evidence of CAV per ISHLT grading

时间窗: 48 months (+/- 6 months) after primary transplantation

Coronary Artery Vasculopathy (CAV) International Society for Heart and Lung Transplantation Registry (ISHLT)

次要结局

  • Incidence of clinical evidence of CAV per ISHLT grading(48 months (+/- 6 months) after primary transplantation)
  • Incidence of death(48 months (+/- 6 months) after primary transplantation)
  • Incidence of re-transplantation or re-listed for transplantation(48 months (+/- 6 months) after primary transplantation)
  • Incidence of myocardial infarction(48 months (+/- 6 months) after primary transplantation)
  • Incidence of coronary stent(48 months (+/- 6 months) after primary transplantation)

研究点 (12)

Loading locations...

相似试验